ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1299

Hitting the Target Together: Supporting Shared Decision-Making with Juvenile Idiopathic Arthritis (JIA) Patients Followed in the Out-Patient Rheumatology Setting at the Hospital for Sick Children

Jo-Anne Marcuz1, Brian Feldman2, Y. Ingrid Goh3, Niina Kim4, Piya Lahiry5, Deborah Levy2, Elizaveta Limenis6, Jeanine McColl7, Christine O'Brien8, Susan Paetkau4, Shirley Tse2, Kristi Whitney8 and Ronald Laxer2, 1Division of Rheumatology and Department of Rehabilitation, The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 2Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children; Child Health Evaluative Services, SickKids Research Institute, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, ON, Canada, 5Division of Rheumatology, The Hospital for Sick Children; Department of Pediatrics, University of Toronto, Toronto, ON, Canada, 6Division of Rheumatology, The Hospital for Sick Children; Department of Paediatrics, University of Toronto, Toronto, ON, Canada, 7Division of Rheumatology, The Hospital for Sick Children; University of Toronto, Toronto, ON, Canada, 8Division of Rheumatology and Department of Rehabilitation, The Hospital for Sick Children, Toronto, ON, Canada

Meeting: ACR Convergence 2022

Keywords: Disease Activity, Juvenile idiopathic arthritis, Pediatric rheumatology, Quality Indicators, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Measures and Measurement of Healthcare Quality Poster

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Juvenile Idiopathic Arthritis (JIA) is the most common chronic rheumatic disease in children with significant morbidity that extends into adulthood. Despite advances in effective JIA treatment over the last 15-20 years, research on treatment adherence, patient satisfaction, clinical outcomes, and self-management show a need to focus on the integration of shared decision-making (SDM). However, implementing SDM has several real and perceived barriers that hinder the success of this patient-centred, evidence-based care. The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) has established a 3-step process to implementing treat to target (T2T): 1) standardized assessment and review of the clinical Juvenile Arthritis Disease Activity Score (cJADAS), a composite score of the physician global assessment (PGA), active joint count (AJC), and patient global assessment (PtGA); 2) setting a treatment target using SDM with the patient, with the cJADAS as a foundational tool; and 3) utilizing clinical decision supports. Our target was to increase completion and review of the cJADAS to >80% and implementation of T2T to 50% with JIA patients by June 2, 2022.

Methods: A nonrandomized, prospective, interrupted time series quality improvement project guided by the Model for Improvement (MFI) framework was initiated in January 2022 and is ongoing. In-person encounters with JIA patients who had an established diagnosis followed in two specific clinics were chosen to measure improvement.Thorough root cause analysis and development of a driver diagram led to several potential change interventions. Iterative plan-do-study-act (PDSA) cycles were then conducted, and data tracked and analyzed using run charts and control charts. Established rules were followed to determine if nonrandom signals of change and variation due to special cause were found when analyzing the data.

Results: Preliminary results up to and including May 2022 illustrate improvement in all measures. Change interventions introduced to date include (1) creation of a standard approach to JIA encounters that highlight the steps to support T2T and (2) automation of the PtGA score entry by increasing on-line completion of the patient reported outcome.There were no startup costs for this project since materials were covered under the clinical operations budget and activities did not significantly extend beyond team members’ current clinical roles.

Conclusion: Preliminary results suggest successful implementation of T2T. The next steps include supporting sustainability and scaling this practice to other clinics. Although no costs were incurred, SDM has been shown in the literature to improve adherence, clinical outcomes, and enhance self-management skills, which can translate to healthcare savings in out-patient care and decreased economic burden and productivity loss in the future for pediatric patients.

Supporting image 1

PGA = physician global assessment; PtGA = patient global assessment; AJC = active joint count; cJADAS = clinical juvenile arthritis disease activity score; T2T = treat to target (specifically “new target” documented).

Supporting image 2

Supporting image 3


Disclosures: J. Marcuz, None; B. Feldman, Pfizer, AB2-Bio, Janssen; Y. Goh, None; N. Kim, None; P. Lahiry, None; D. Levy, None; E. Limenis, None; J. McColl, None; C. O'Brien, None; S. Paetkau, None; S. Tse, None; K. Whitney, None; R. Laxer, Eli Lilly, Novartis, sanofi, sobi.

To cite this abstract in AMA style:

Marcuz J, Feldman B, Goh Y, Kim N, Lahiry P, Levy D, Limenis E, McColl J, O'Brien C, Paetkau S, Tse S, Whitney K, Laxer R. Hitting the Target Together: Supporting Shared Decision-Making with Juvenile Idiopathic Arthritis (JIA) Patients Followed in the Out-Patient Rheumatology Setting at the Hospital for Sick Children [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/hitting-the-target-together-supporting-shared-decision-making-with-juvenile-idiopathic-arthritis-jia-patients-followed-in-the-out-patient-rheumatology-setting-at-the-hospital-for-sick-children/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hitting-the-target-together-supporting-shared-decision-making-with-juvenile-idiopathic-arthritis-jia-patients-followed-in-the-out-patient-rheumatology-setting-at-the-hospital-for-sick-children/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology